Indeed, as reported by a phase 1b clinical study, PD‐1/PD‐L1 axis‐based immune checkpoint blockade failed to control MM progression,16, 17 suggesting that this checkpoint may not be the major mediator of failing anti‐MM immunity. This evidence concerns the gene PDCD1 and Miyoshi myopathy.